Here's why ASX 200 health insurance shares like Medibank are being trounced today

Investors are feeling a bit sick after the latest update.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) health insurance shares such as Medibank Private Ltd (ASX: MPL) are underperforming the index today for one key reason. At the moment, the Medibank share price is down 0.7%, while the ASX 200 is down 0.2%.

Unlike many other industries, how much money the private health insurance sector can make is somewhat controlled by the Federal Government.

The Australian Government ultimately approves the premium increases that the private health insurance businesses want to enact.

The next premium hikes could be elevated, with news breaking today of how much more Aussies may be paying.

ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

Large premium increases requested

According to reporting by the Australian Financial Review, private health insurers are going to ask the Labor Government to increase premiums by twice as much as last time.

AFR sources with detailed knowledge of the discussions estimate that private health insurers will increase premiums by 5% to 6% in April, the largest increase since 2016.

Large insurers have given early estimates of costs, including forecasts of payments to private hospitals and medical treatment.

The NIB Holdings Limited (ASX: NHF) share price is currently down 0.9%, as one of the other major players in the space. The NIB CEO Mark Fitzgibbon said:

I expect (in the) longer run claims inflation will run at 4% to 6% and right now. That is keeping with what we have seen for 24 years when claims have generally grown at 5.5% per annum.

There has always been heavy scrutiny on premium increases as there always has been. Ultimately, we have to cover claims inflation like any insurer because if you don't eventually you go out of business.

Last time, Health Minister Mark Butler granted a premium increase that was about half of what private health funds, such as ASX 200 health insurance shares, had wanted.

The AFR reported that insurance businesses think premium increases should return to pre-COVID levels, considering the cost of treatment and the number of surgeries is rising again.

The newspaper noted that analysts and healthcare experts said it was "unlikely the government would approve an increase above 3%".

Terry Barnes, a health policy consultant and former adviser to the Howard government, said:

The government will be very nervous about anything more than 2% to 3%. The government of the days wants premiums to increase at the lowest possible rate and this year of all years will be running the ruler very closely over applications.

Medibank share price snapshot

Since the start of 2024, Medibank shares have risen 3.2%, compared to a rise of 8.8% for the ASX 200.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman smiles at the outlook she sees through binoculars.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can this business deliver very healthy gains from here?

Read more »

Group of scientists cheering in the lab after the company received good news.
Healthcare Shares

Why is this ASX biotech stock blasting higher today?

Investors are backing the biotech's growing commercial and pipeline potential.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

Down 30%, should I buy ResMed shares now?

A sharp fall can make investors cautious, but it can also create opportunity when the long-term business remains strong.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

3 beaten-down ASX healthcare shares tipped to rise up to 202%

Analysts have a strong buy rating on two of these healthcare stocks, and all three are tipped to have an…

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Share Market News

Investors are buying CSL shares again. Should you?

Some experts believe that 2026 could mark the low point for the biotech company.

Read more »

A group of young people celebrate and party outside.
Healthcare Shares

If I'd invested $5,000 in 4DMedical shares 12 months ago, guess how much I'd have now!

Can the company's share price keep accelerating even higher? Here's what analysts tip for the next 12 months.

Read more »

Stressed, unhappy, and tired scientist with a headache working on a computer in a lab.
Healthcare Shares

3 reasons I'd buy CSL shares in FY27

It still needs to rebuild trust, but lower expectations and several recovery levers make the shares worth considering.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Healthcare Shares

CSL shares jump 15%: Is it time to start buying the beaten-down biotech stock?

CSL shares have climbed 7% higher over the past week alone.

Read more »